FDA Advisory Panel Rejects Novel ALS Drug FDA Advisory Panel Rejects Novel ALS Drug

A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news